Trial Details
RECRUITINGBasic Information
| Clinical ID | c599 |
|---|---|
| Identifier | NCT06351124 |
| Trial Title | Beta-Hydroxybutyrate Feasibility Treating IBD |
| Trial URL | Visit Original Page |
Study Information
| Study Results | NO |
|---|---|
| Conditions | Crohn's Disease|Inflammatory Bowel Diseases |
| Interventions | BIOLOGICAL: Feasibility of beta-hydroxybutyrate supplementation to reduce inflammation in patients with Crohn's |
Participant Information
| Sponsor | University of Texas at Austin |
|---|---|
| City | Austin |
| Country/Region | United States |
Enrollment Criteria
| Sex Requirement | ALL |
|---|---|
| Age Requirement | ADULT, OLDER_ADULT |
Study Design
| Study Type | INTERVENTIONAL |
|---|---|
| Phase | PHASE1|PHASE2 |
Time Information
| Start Date | 2024-08-28 |
|---|---|
| Primary Completion Date | 2025-04-01 |
| Completion Date | 2025-12-31 |